Cleared Traditional

K843930 - IRMA IMMUNORADIOMETRIC ASSAY-FSH 125I

K843930 is an FDA 510(k) clearance for IRMA IMMUNORADIOMETRIC ASSAY-FSH 125I, manufactured by Euro-Diagnostics BV. The device is a Class 1 Immunology device with product code CGJ cleared through the Traditional 510(k) pathway after a 25-day FDA review.

K843930 · Euro-Diagnostics BV · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1984
Decision
25d
Days
Class 1
Risk

K843930 is an FDA 510(k) clearance for the IRMA IMMUNORADIOMETRIC ASSAY-FSH 125I. Classified as Radioimmunoassay, Follicle-stimulating Hormone (product code CGJ), Class I - General Controls.

Submitted by Euro-Diagnostics BV (Old Greenwich, US). The FDA issued a Cleared decision on October 30, 1984 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1300 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Euro-Diagnostics BV devices

FDA 510(k) Submission Details - K843930

510(k) Number K843930 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 1984
Decision Date October 30, 1984
Days to Decision 25 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 105d · This submission: 25d
Pathway characteristics
Predicate-based equivalence.

CGJ Device Classification - Class 1, General Controls

Product Code CGJ Radioimmunoassay, Follicle-stimulating Hormone
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1300
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGJ Radioimmunoassay, Follicle-stimulating Hormone

All 70
Devices cleared under the same product code (CGJ) and FDA review panel - the closest regulatory comparables to K843930.
LEE-BEAD BETA FSH (EIA)
K854837 · Leeco Diagnostics, Inc. · Jan 1986
PARAAMAX CHLORIDE DETERMINATION BY ISE
K854651 · American Dade · Dec 1985
AMERLEX-M FOLLICLE STIMULATING HORMONE(FSH)RADIOIM
K851361 · Amersham Corp. · May 1985
FSH RIA
K842444 · Syncor Intl. Corp. · Aug 1984
FSH QUIK RIA KIT
K840230 · Pacific Biotech, Inc. · Mar 1984
RIANEN FOLLICLE STIMULATING HORMONE
K834038 · New England Nuclear · Jan 1984